切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 566 -569. doi: 10.3877/cma.j.issn.1674-3946.2024.05.026

论著

腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究
崔宏帅1, 冯丽明1, 东维玲1, 韩博1,()   
  1. 1. 266000 山东 青岛,康复大学青岛中心医院(青岛市中心医院)胃肠外科
  • 收稿日期:2024-02-19 出版日期:2024-10-26
  • 通信作者: 韩博

The clinical effect of laparoscopic D3 radical resection of right half colon cancer plus IGLN dissection in the treatment of locally advanced hepatocolon carcinoma

Hongshuai Cui1, Liming Feng1, Weiling Dong1, Bo Han1,()   

  1. 1. Department of Gastroenterology, Qingdao Central Hospital of Rehabilitation University (Qingdao Central Hospital) , Qingdao Shandong Province 266000, China
  • Received:2024-02-19 Published:2024-10-26
  • Corresponding author: Bo Han
引用本文:

崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.

Hongshuai Cui, Liming Feng, Weiling Dong, Bo Han. The clinical effect of laparoscopic D3 radical resection of right half colon cancer plus IGLN dissection in the treatment of locally advanced hepatocolon carcinoma[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 566-569.

目的

探讨腹腔镜右半结肠癌D3根治术+幽门下和胃网膜弓淋巴结(IGLN)清扫术治疗局部进展期结肠肝曲癌的临床疗效。

方法

回顾性分析2018年5月至2023年10月60例局部进展期结肠肝曲癌患者资料。根据淋巴结清扫范围不同分为观察组和对照组,每组患者各30例。对照组行腹腔镜右半结肠癌D3根治术,观察组行右半结肠癌D3根治结合IGLN清扫术。采用统计学软件SPSS 22.0分析数据。围手术期指标等计量资料用()表示,行独立样本t检验;并发症等计数资料用[例(%)]表示,采用χ2检验或Fisher精确概率法;应用Kaplan-Meier 法分析预后生存情况。P<0.05表示差异有统计学意义。

结果

两组患者手术时间、术中出血量、淋巴结清扫数目、首次排气时间及住院时间差异均无统计学意义(P>0.05);共获取IGLN淋巴结480个,其中IGLN阳性率为15.4%。观察组患者总并发症虽多于对照组,但差异无统计学意义(P>0.05),均采取保守治疗后痊愈。Kaplan-Meier生存分析显示,观察组患者5年累积总生存率与累积无病生存率(76.7%、66.7%)明显高于对照组患者(53.3%、46.7%),差异有统计学意义(P<0.05)。

结论

术中应用右半结肠癌D3根治术联合IGLN清扫术治疗局部进展期结肠肝曲癌可提高患者预后生存且安全可行,具有临床推广前景及价值。

Objective

To investigate the clinical effect of laparoscopic D3 radical resection of right hemicolonic carcinoma plus subpyloric and gastroepiploic lymph node (IGLN) dissection in the treatment of locally advanced hepatocolon carcinoma.

Methods

The data of 60 patients with locally advanced hepatocellular carcinoma from May 2018 to October 2023 were retrospectively analyzed. The patients were divided into observation group and control group according to the different scope of lymph node dissection, 30 patients in each group. The control group underwent laparoscopic D3 radical resection of right hemicoloma carcinoma, and the observation group underwent D3 radical resection of right hemicoloma carcinoma combined with IGLN dissection. Statistical software SPSS 22.0 was used to analyze the data. Perioperative indicators and other measurement data were expressed with (), and independent sample t test was performed. Complications and other statistical data were represented by [cases (%)] using χ2 test or Fisher exact probability method. Kaplan-Meier method was used to analyze the prognosis and survival. P<0.05 indicated that the difference was statistically significant.

Results

There were no significant differences in operation time, intraoperative blood loss, number of lymph dissection, first exhaust time and hospital stay between the two groups (P>0.05). A total of 480 IGLN lymph nodes were obtained, of which the positive rate of IGLN was 15.4%. The total complications in the observation group were higher than those in the control group, but the difference was not statistically significant (P>0.05), and all patients were cured after conservative treatment. Kaplan-Meier survival analysis showed that 5-year cumulative overall survival and disease-free survival (76.7% and 66.7%) in the observation group were significantly higher than those in the control group (53.3% and 46.7%), and the difference was statistically significant (P<0.05).

Conclusion

Intraoperative application of D3 radical resection of right half colon cancer combined with IGLN dissection in the treatment of locally advanced hepatocolon carcinoma can improve the prognosis and survival of patients, and is safe and feasible, which has the prospect and value of clinical promotion.

表1 两组患者一般资料比较
表2 两组患者围手术期指标比较
表3 两组患者术后并发症比较[例(%)]
图1 两组患者生存情况比较
[1]
刘宗超,李哲轩,张阳,等. 2020全球癌症统计报告解读[J/CD]. 肿瘤综合治疗电子杂志2021,7(02):1-13.
[2]
Piozzi GNRusli SMBaek SJ,et al. Infrapyloric and gastroepiploic node dissection for hepatic flexure and transverse colon cancer: A systematic review. Eur J Surg Oncol[J]. 2022,48(4):718-726.
[3]
李明,杨庆强. 结肠肝曲癌淋巴结转移规律及影响因素的前瞻性临床分析[J]. 医学研究杂志2022,51(10):147-150,142.
[4]
Huynh Thanh LNguyen Manh KNguyen Thi M,et al. Results of Laparoscopic Surgery and D3 Lymph Node Dissection Combined With Chemotherapy for the Radical Treatment of Advanced-Stage Right Colon Cancer: A Single-Center Observational Study in Vietnam. Cureus[J]. 2023,15(8):e43243.
[5]
Wang XHuang SLu X,et al. Incidence of and Risk Factors for Gastroepiploic Lymph Node Involvement in Patients with Cancer of the Transverse Colon Including the Hepatic Flexure. World J Surg[J]. 2021,45(5):1514-1525.
[6]
易小江,冯晓创,李洪明,等. 结肠肝曲癌腹腔镜扩大右半结肠癌D3根治术中行幽门下组淋巴结清扫的临床资料分析[J]. 结直肠肛门外科2022,28(03):280-284.
[7]
Lin YSun YLin H,et al. Prediction of prolonged resolution of chylous ascites after radical D3 resection for colorectal cancer: A population-based experience from a high-volume center. Eur J Surg Oncol[J]. 2022,48(1):204-210.
[8]
Kim JSBaek SJKwak JM,et al. Impact of D3 lymph node dissection on upstaging and short-term survival in clinical stage I right-sided colon cancer. Asian J Surg[J]. 2021,44(10):1278-1282.
[9]
王凌风,林圣涛,杨常顺,等. 右半结肠D3淋巴结清扫术对腹腔镜右半结肠癌根治术患者疗效分析[J/CD]. 中华普外科手术学杂志(电子版)2022,16(05):499-501.
[10]
陆雄,陈海伟,刘益民,等. 3D腹腔镜右半结肠癌根治术对内脏型肥胖患者淋巴结清扫的应用价值[J/CD]. 中华普外科手术学杂志(电子版)2022,16(03):311-314.
[11]
Benz SRFeder ISVollmer S,et al. Complete mesocolic excision for right colonic cancer: prospective multicentre study[J]. 2022,110(1):98-105.
[12]
Wang LSong BChen Y,et al. D3 lymph node dissection improves the survival outcome in patients with pT2 colorectal cancer[J]. 2023,38(1):30.
[13]
朱德祥,任黎,许剑民. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J/CD]. 消化肿瘤杂志(电子版)2023,15(02):86-99.
[14]
Herrera MBerral-González ALópez-Cade I,et al. Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients. Mol Cancer[J]. 2021,20(1):73.
[15]
Petz WBertani EBorin S,et al. Fluorescence-guided D3 lymphadenectomy in robotic right colectomy with complete mesocolic excision. Int J Med Robot[J]. 2021,17(3):e2217.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要